Investor Relations News

08. Januar 2025

Evonik successfully issues third green bond

Evonik Industries AG successfully issued a green bond today

  • Bond issuance secures funding for 2025 early in the year
  • Net proceeds of green bond primarily used to contribute to the sustainable transformation of Evonik
  • Volume of €500 million with maturity in 2030 fits well into balanced maturity profile

Essen, Germany. Evonik Industries AG successfully issued a green bond today with a nominal volume of €500 million to address financing needs in 2025, including a conventional bond maturity in September 2025 in the same volume. The green senior unsecured bond is already the third consecutive green bond issued by Evonik, demonstrating the continued integral role of sustainability within its financing strategy. The corresponding Green Finance Framework is based on the ICMA Green Bond Principles, was last updated in 2023 and reviewed by a second party opinion from ISS in 2023.

“With the successful issuance today, we have already secured our funding for 2025 early in the year and are further supporting our green transformation”, said Maike Schuh, Chief Financial Officer of Evonik.

The majority of green bond proceeds will be used to further expand our portfolio of Next Generation Solutions and Next Generation Technologies. These include, among other things, investments into lipids for mRNA-based medicine, membranes for efficient gas separation or aluminum oxides as battery materials for e-mobility, as well as the development of a climate-neutral alkoxides production in Singapore.

The green bond was significantly oversubscribed and generated strong interest from a broad base of investors, including institutional investors with a strong focus on sustainability. The interest coupon is 3.25 % per year with a term of 5 years. The bond will be rated in line with the ratings of Evonik Industries AG, which are a Baa2 (outlook stable) at Moody’s and BBB+ at S&P (outlook stable).

The issuance was arranged by J.P. Morgan as global coordinator and Citibank, Helaba, HSBC, J.P. Morgan and Société Générale as joint bookrunners.

Über Evonik

Evonik ist ein weltweit führendes Unternehmen der Spezialchemie. Der Konzern ist in über 100 Ländern aktiv und erwirtschaftete 2023 einen Umsatz von 15,3 Mrd. € und ein Ergebnis (bereinigtes EBITDA) von 1,66 Mrd. €. Dabei geht Evonik weit über die Chemie hinaus, um den Kunden innovative, wertbringende und nachhaltige Lösungen zu schaffen. Rund 32.000 Mitarbeiter verbindet dabei ein gemeinsamer Antrieb: Wir wollen das Leben besser machen, Tag für Tag.

Disclaimer

This IR News constitutes neither an offer to sell nor a solicitation of an offer to buy securities. In particular, this document constitutes neither an offer to sell nor a solicitation of an offer to purchase securities in the United States. The securities of Evonik Industries AG described above (the "Securities") may not be offered or sold in the United States or to or for the account or benefit of "U.S. persons" (as such term is defined in Regulation S under the U. S. Securities Act of 1933, as amended (the "Securities Act")) absent registration or an exemption from registration under the Securities Act. The Securities have not been and will not be registered under the Securities Act or the securities laws of any State of the United States. There will be no public offering of the Securities in the United States.

 

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this IR News.